Biofrontera Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 4.2yrs |
| Board average tenure | 2.1yrs |
Recent management updates
Recent updates
Biofrontera AG (ETR:B8FK) Surges 30% Yet Its Low P/S Is No Reason For Excitement
Oct 13
Biofrontera AG (ETR:B8FK) Not Doing Enough For Some Investors As Its Shares Slump 47%
May 21Why Investors Shouldn't Be Surprised By Biofrontera AG's (ETR:B8F) 30% Share Price Plunge
Mar 07We're Keeping An Eye On Biofrontera's (ETR:B8F) Cash Burn Rate
Feb 19Here's Why It's Unlikely That Biofrontera AG's (ETR:B8F) CEO Will See A Pay Rise This Year
Dec 07Does Biofrontera (ETR:B8F) Have A Healthy Balance Sheet?
Jun 08Biofrontera AG (ETR:B8F) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Apr 14CEO
Biofrontera has no CEO, or we have no data on them.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CFO & Member of Executive Board | 2.7yrs | €425.00k | no data | |
| Member of the Executive Board | 4.2yrs | €435.65k | no data | |
| Head of UK Sales Team | 7yrs | no data | no data | |
| Head of Sales & Marketing - Europe | 5.3yrs | no data | no data | |
| Managing Director of Biofrontera UK Ltd. | 2.4yrs | no data | no data |
4.2yrs
Average Tenure
Experienced Management: B8FK's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Head of the Scientific Advisory Board | no data | no data | no data | |
| Member of Supervisory Board | less than a year | €8.00k | no data | |
| Member of the Supervisory Board | 3.4yrs | €22.00k | no data | |
| Vice Chairman of the Supervisory Board | 3.4yrs | €34.00k | no data | |
| Chairman of Supervisory Board | less than a year | €15.00k | no data | |
| Member of the Supervisory Board | 3.4yrs | €28.00k | no data | |
| Member of Supervisory Board | less than a year | no data | no data |
2.1yrs
Average Tenure
53yo
Average Age
Experienced Board: B8FK's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/05 19:21 |
| End of Day Share Price | 2025/05/05 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Biofrontera AG is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Raymond Myers | Benchmark Company |
| Navid Malik | Cavendish Historical (Cenkos Securities) |
| Robert Wasserman | Dawson James Securities |